Session 8: Accelerated approval pathways: Do the benefits really outweigh the costs?

Name: Session 8: Accelerated approval pathways: Do the benefits really outweigh the costs?
Start: 2027-01-21T10:00
End: 2027-01-21T11:00
Location: San Diego Convention Center

Advanced Therapies Week 2027 · 21 January 2027 · 10:00–11:00 · Theatre 4

Session 8: Accelerated approval pathways: Do the benefits really outweigh the costs? was a session at Advanced Therapies Week 2027 on 21 January 2027 in San Diego, with 3 speakers on record.

Speakers

Chris Juenger — Speaker Director, Lead, North America Regulatory Science, Policy and Intelligence, CSL
Noelle Harff — Speaker Technology and Biotech Reporter, San Diego Union-Tribune
Snehal Naik — Speaker Vice President, Science and Regulatory, BIO